Abstract
Biodegradable materials used for drug delivery are of great demand due to their ability to degrade into low molecular weight species and further excrete from the body by metabolism. Herein, we report a new kind of zinc(II) crosslinked poly(methacrylic acid) nanohydrogels (ZCLNs) inspired by zinc finger proteins with dual stimuli-triggered degradation (glutathione and pH) for the first time. Compared with the disulfide bond crosslinked nanohydrogels, this new kind of ZCLNs is beneficial to the degradation of a wide range of cells, including normal cells. Ex vivo fluorescence images showed that the DOX-loaded folate-PEG conjugated zinc(II)-crosslinked polymeric nanohydrogels (FPZCLNs-15) preferentially accumulated in tumor tissue and the accumulation in normal tissues was much less compared with DOX-loaded PZCLNs-15 (non-targeted nanohydrogels) and free DOX, the FPZCLNs-15 (targeting system) delivered DOX to the tumor site with approximately 3.6- and 1.6-fold higher than free DOX and PZCLNs-15, respectively. Meanwhile, the PZCLNs-15 and FPZCLNs-15 reduced the concentration of DOX in the heart by 3.2- and 5.0-fold respectively, as compared to the free DOX. Moreover, a superior tumor growth inhibition and negligible damage to normal organs like the heart and kidney, which is reported to be vulnerable to DOX-associated side effects, are further demonstrated.
Keywords:
Coordination substitution; Folate-PEG conjugation; Glutathione/pH triggered degradation; Targeted drug delivery; Zinc(II)-crosslinked nanohydrogels.
Copyright © 2016 Elsevier B.V. All rights reserved.
Publication types
-
Research Support, Non-U.S. Gov't
MeSH terms
-
Animals
-
Antineoplastic Agents / administration & dosage*
-
Antineoplastic Agents / chemistry
-
Antineoplastic Agents / pharmacokinetics
-
Antineoplastic Agents / therapeutic use
-
Cell Survival / drug effects
-
Doxorubicin / administration & dosage*
-
Doxorubicin / chemistry
-
Doxorubicin / pharmacokinetics
-
Doxorubicin / therapeutic use
-
Drug Delivery Systems
-
Drug Liberation
-
Female
-
Folic Acid / administration & dosage
-
Folic Acid / analogs & derivatives*
-
Folic Acid / chemistry
-
Folic Acid / pharmacokinetics
-
Folic Acid / therapeutic use
-
Glutathione / metabolism
-
HEK293 Cells
-
HeLa Cells
-
Humans
-
Hydrogels / administration & dosage*
-
Hydrogels / chemistry
-
Hydrogels / pharmacokinetics
-
Hydrogels / therapeutic use
-
Hydrogen-Ion Concentration
-
Mice, Inbred BALB C
-
Nanostructures / administration & dosage
-
Nanostructures / chemistry
-
Nanostructures / therapeutic use
-
Neoplasms / drug therapy
-
Neoplasms / metabolism
-
Neoplasms / pathology
-
Polyethylene Glycols / administration & dosage*
-
Polyethylene Glycols / chemistry
-
Polyethylene Glycols / pharmacokinetics
-
Polyethylene Glycols / therapeutic use
-
Polymethacrylic Acids / administration & dosage*
-
Polymethacrylic Acids / chemistry
-
Polymethacrylic Acids / pharmacokinetics
-
Polymethacrylic Acids / therapeutic use
-
Tumor Burden / drug effects
-
Zinc / administration & dosage*
-
Zinc / chemistry
-
Zinc / pharmacokinetics
-
Zinc / therapeutic use
-
Zinc Fingers
Substances
-
Antineoplastic Agents
-
Hydrogels
-
Polymethacrylic Acids
-
poly(ethylene glycol)-folate
-
polymethacrylic acid
-
Polyethylene Glycols
-
Doxorubicin
-
Folic Acid
-
Glutathione
-
Zinc